Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Cortes

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Cancer|August 1, 1997
Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemiaE J Rodriguez-Monge, J E Cortes, S O'Brien, et al.
International Journal of Laboratory Hematology|June 19, 2015
Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasmZ Chen, W Wang, S Verstovsek, et al.
Leukemia|January 1, 1995
Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromesJ E Cortes, H Kantarjian, S O'Brien, et al.
Cancer|January 15, 1995
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up resultsJ E Cortes, M Talpaz, M Beran, et al.
Cancer|April 8, 1999
A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remissionJ E Cortes, H M Kantarjian, S O'Brien, et al.
Leukemia|September 10, 2005
Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemiaH Gao, B-N Lee, M Talpaz, et al.
Cancer|January 28, 1999
Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literatureA Aguayo, J E Cortes, H M Kantarjian, et al.
Cancer|June 15, 1994
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemiaJ E Cortes, H Kantarjian, S O'Brien, et al.
European Journal of Cancer Care|May 25, 2013
A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndromeN Daver, A Vega-Ruiz, H M Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2013
Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complicationsI I Raad, A M Chaftari, M M Al Shuaibi, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Cancer|August 1, 1997
Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemiaE J Rodriguez-Monge, J E Cortes, S O'Brien, et al.
International Journal of Laboratory Hematology|June 19, 2015
Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasmZ Chen, W Wang, S Verstovsek, et al.
Leukemia|January 1, 1995
Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromesJ E Cortes, H Kantarjian, S O'Brien, et al.
Cancer|January 15, 1995
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up resultsJ E Cortes, M Talpaz, M Beran, et al.
Cancer|April 8, 1999
A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remissionJ E Cortes, H M Kantarjian, S O'Brien, et al.
Leukemia|September 10, 2005
Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemiaH Gao, B-N Lee, M Talpaz, et al.
Cancer|January 28, 1999
Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literatureA Aguayo, J E Cortes, H M Kantarjian, et al.
Cancer|June 15, 1994
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemiaJ E Cortes, H Kantarjian, S O'Brien, et al.
European Journal of Cancer Care|May 25, 2013
A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndromeN Daver, A Vega-Ruiz, H M Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2013
Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complicationsI I Raad, A M Chaftari, M M Al Shuaibi, et al.
Pageof 5